Trial Profile
A Multicenter Randomized Phase III Study on Adjuvant Therapy with Edrecolomab versus Observation in Stage II Colon Cancer.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 08 Sep 2016
Price :
$35
*
At a glance
- Drugs Edrecolomab (Primary)
- Indications Colon cancer
- Focus Therapeutic Use
- 03 Oct 2001 New trial record